{"id":"W2486559230","doi":"10.1038/nrdp.2016.39","title":"Systemic lupus erythematosus","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1355,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Belimumab; Medicine; Disease; Immunology; Systemic lupus erythematosus; Adverse effect; Immune dysregulation; Autoimmune disease; Immune system; Internal medicine; B-cell activating factor; B cell; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}